Delivery Order SPE2DR25D1109-SPE2DR26FFF7N
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $20,289.80 to AmerisourceBergen Drug Corp for the supply of Imitrex 6 mg/0.5 ml pen injectors on April 21, 2025, with an ultimate completion date of April 22, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order executed under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's headquarters location in...
- The Defense Logistics Agency awarded a $5,405.03 delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Imitrex 4 mg/0.5 mL pen injections (0.5 mL units). The contract represents a firm fixed price delivery order with an ultimate completion date of April 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injectors valued at $2,410.63. This is a firm fixed price delivery order with an ultimate completion date of September 30, 2025, and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,712.54 to AmerisourceBergen Drug Corp for Imitrex 6 mg/0.5 ml pen injections on August 7, 2025, with an ultimate completion date of August 8, 2025. This competitive award carries firm fixed pricing and involves no set-aside designation. The pharmaceutical product will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $4,211.79 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injectors. This firm fixed price, non-set-aside contract is scheduled for completion by August 1, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's extensive pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Imitrex 6 mg/0.5 ml pen injectors valued at $2,443.61. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award to the qualified vendor. The order is scheduled for ultimate completion on April 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a $4,896.10 delivery order by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injectors. This firm fixed-price contract, designated as a non-set-aside award, is scheduled for completion by July 29, 2025, with performance to be executed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injectors in 0.5 mL quantities. This firm fixed-price delivery order, valued at $1,071.96, is scheduled for completion by September 9, 2025, and will be performed at the awardee's Conshohocken, Pennsylvania facility. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $2,595.76 firm fixed price delivery order to AmerisourceBergen Drug Corp for Imitrex 4 mg/0.5 mL pen injections on July 24, 2025, with an ultimate completion date of July 25, 2025. This non-set-aside award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injectors with a firm fixed price ceiling value of $1,501.15 and completion date of July 31, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFF7NDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,105.93 to AmerisourceBergen Drug Corp for Imitrex 6 mg/0.5 ml pen injections on October 29, 2025, with completion expected by October 30, 2025. This firm fixed price delivery order represents a pediatric or standard-dose pharmaceutical supply for migraine treatment and falls under a non-competitive, non-set-aside procurement. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and primary distribution center. This delivery order is issued against AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a $999.99 billion comprehensive pharmaceutical prime vendor agreement extending through December 2026. The IDC serves as the primary vehicle for supplying a broad portfolio of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities to support military and federal healthcare systems globally, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's status as a major pharmaceutical distributor and its demonstrated capability across multiple therapeutic domains positions it as a critical supplier within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 10/29/25 |